UK Dividends Calendar - Week Ahead
9th May 2014 05:26
LONDON (Alliance News) - GlaxoSmithKline PLC Thursday said that it has been granted marketing authorisation in Europe for Anoro Ellipta, as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease. Anoro Ellipta is a once-daily Read More
LONDON (Alliance News) - Shares have opened lower Wednesday amid continued concerns about the deteriorating situation in Ukraine and some disappointing data from China and Europe.<br /><br />In his last annual results presentation as <strong>Sainsbury's</strong> chief executive, Justin King re Read More
LONDON (Alliance News) - Pharmaceutical giant GlaxoSmithKline PLC Friday said Chief Executive Officer Andrew Witty made several share transactions on May 1. Witty transferred by way of gift 500 shares in the company to each of his two children, and also sold 731 shares at 1,629.0550 pence e Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Thursday morning:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />GOLDMAN RAISES WILLIAM HILL PRICE TARGET TO 395 (385) PENCE - 'BUY' <br />----------<br />DEUTSCHE BANK RAISES WHITBREAD PRICE Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Wednesday said FDA has approved Incruse Ellipta, or umeclidinium, as treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and/or emphysema. Umeclidinium is GSK's first once-daily an Read More
LONDON (Alliance News) - The FTSE 100 closed marginally higher Wednesday, adding to gains posted on Monday and Tuesday, and ensuring that the blue-chip index closed the month of April firmly higher than it opened it. <br /><br />Meanwhile, it was a volatile day in the forex market following a Read More
LONDON (Alliance News) - Drugs giant GlaxoSmithKline PLC Wednesday reported a drop in revenue and net profit for the first quarter due to asset sales and a decline in sales of pharmaceuticals in the US, but the company also raised its dividend and reiterated its full-year profit guidance despite Read More
LONDON (Alliance News) - <strong>GlaxoSmithKline</strong> PLC Wednesday reported a drop in revenue and net profit for the first quarter due to asset sales and a decline in sales of pharmaceuticals in the US, but the company also raised its dividend and reiterated its full-year profit guidance Read More
LONDON (Alliance News) - US equities are set to open marginally lower Wednesday, as investors digest the latest tranche of quarterly trading statements released after the Wall Street close on Tuesday, and ahead of some important US macroeconomic data and the latest Federal Open Market Committee p Read More
LONDON (Alliance News) - Drugs giant GlaxoSmithKline PLC Wednesday reported a drop in revenue and net profit for the first quarter due to asset sales and a decline in sales of pharmaceuticals in the US, but the company also raised its dividend and reiterated its full-year profit guidance despite Read More
LONDON (Alliance News) - UK stocks trade mixed Wednesday, as investors await a raft of releases from the US and after the preliminary reading of eurozone consumer price inflation accelerated from a more than four-year low, but still missed forecasts. By mid-morning, the FTSE 100 is marginal Read More
(An item published at 0745 BST misstated the time GlaxoSmithKline is due to release its first-quarter results. The correct time follows.) Pharmaceutical giant GlaxoSmithKline is due to publish its first quarter results at 1100 GMT. By James Kemp; [email protected]; @jamespkem Read More
LONDON (Alliance News) - UK equities are set to open flat to slightly lower Wednesday, following some strong gains posted on Tuesday, as investors take their positions ahead of important macro economic releases from Europe and the US. Meanwhile, market participants in London face another da Read More
LONDON (Alliance News) - The FTSE 100 closed higher for the second day in a row Tuesday, ending the day at its highest closing level since March 6, buoyed in part by a strong performance by oil major BP and drugs company Shire.<br /><br />Meanwhile, it was a volatile day for the pound. Sterlin Read More
LONDON (Alliance News) - Respiratory treatment development company Vectura Group PLC Tuesday said it has triggered a GBP2 million milestone payment from GlaxoSmithKline PLC, a day after the drugs giant launched its chronic obstructive pulmonary disease treatment Anoro Ellipta in the US. Gla Read More